Mariner’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.8K | Sell |
12,973
-1,263
| -9% | -$1.15K | ﹤0.01% | 3449 |
|
|
2025
Q1 | $6.43K | Sell |
14,236
-606
| -4% | -$274 | ﹤0.01% | 3422 |
|
|
2024
Q4 | $7.46K | Buy |
14,842
+2
| +0% | +$1 | ﹤0.01% | 3372 |
|
|
2024
Q3 | $13.4K | Hold |
14,840
| – | – | ﹤0.01% | 3261 |
|
|
2024
Q2 | $14.8K | Sell |
14,840
-2,000
| -12% | -$2K | ﹤0.01% | 3121 |
|
|
2024
Q1 | $24.9K | Buy |
16,840
+2,000
| +13% | +$2.96K | ﹤0.01% | 3082 |
|
|
2023
Q4 | $16.2K | Sell |
14,840
-17,162
| -54% | -$18.7K | ﹤0.01% | 3008 |
|
|
2023
Q3 | $37.8K | Buy |
32,002
+28
| +0.1% | +$33 | ﹤0.01% | 2796 |
|
|
2023
Q2 | $45.1K | Buy |
31,974
+18,134
| +131% | +$25.6K | ﹤0.01% | 2725 |
|
|
2023
Q1 | $21K | Sell |
13,840
-44
| -0.3% | -$67 | ﹤0.01% | 2723 |
|
|
2022
Q4 | $16K | Sell |
13,884
-343
| -2% | -$395 | ﹤0.01% | 2697 |
|
|
2022
Q3 | $16K | Buy |
+14,227
| New | +$16K | ﹤0.01% | 2397 |
|
|
2019
Q3 | – | Sell |
-60,295
| Closed | -$66K | – | 887 |
|
|
2019
Q2 | $66K | Buy |
+60,295
| New | +$66K | ﹤0.01% | 1089 |
|